| no |
title |
author |
magazine |
year |
volume |
issue |
page(s) |
type |
| 1 |
Activity and safety of a prolonged daily schedule of zoledronic acid in a patient with bone metastases from urothelial carcinoma
|
Brizzi, M.P.
|
|
|
20 |
2 |
p. 389-390
|
article
|
| 2 |
Alemtuzumab and DHAP (A-DHAP) is effective for relapsed peripheral T-cell lymphoma, unspecified: interim results of a phase II prospective study
|
Kim, S.J.
|
|
|
20 |
2 |
p. 390-392
|
article
|
| 3 |
A phase I study of full-dose gemcitabine and regional arterial infusion of nafamostat mesilate for advanced pancreatic cancer
|
Uwagawa, T.
|
|
|
20 |
2 |
p. 239-243
|
article
|
| 4 |
Arterial hypertension correlates with clinical outcome in colorectal cancer patients treated with first-line bevacizumab
|
Scartozzi, M.
|
|
|
20 |
2 |
p. 227-230
|
article
|
| 5 |
Association of the ABCB1 gene polymorphisms 2677G>T/A and 3435C>T with clinical outcomes of paclitaxel monotherapy in metastatic breast cancer patients
|
Chang, H.
|
|
|
20 |
2 |
p. 272-277
|
article
|
| 6 |
Blood pressure as a potential biomarker of the efficacy angiogenesis inhibitor
|
Lévy, B.I.
|
|
|
20 |
2 |
p. 200-203
|
article
|
| 7 |
Breast cancer in women younger than 25: clinicopathological features and prognostic factors
|
Yao, S.
|
|
|
20 |
2 |
p. 387-389
|
article
|
| 8 |
Cancer in adolescents and young adults in north Netherlands (1989–2003): increased incidence, stable survival and high incidence of second primary tumours
|
van Gaal, J.C.
|
|
|
20 |
2 |
p. 365-373
|
article
|
| 9 |
Detection of circulating tumor cells in patients with urothelial cancer
|
Gallagher, D.J.
|
|
|
20 |
2 |
p. 305-308
|
article
|
| 10 |
Development and daily use of an electronic oncological patient record for the total management of cancer patients: 7 years’ experience
|
Galligioni, E.
|
|
|
20 |
2 |
p. 349-352
|
article
|
| 11 |
Economic evaluation of taxane-based first-line chemotherapy in the treatment of patients with metastatic breast cancer in Greece: an analysis alongside a multicenter, randomized phase III clinical trial
|
Maniadakis, N.
|
|
|
20 |
2 |
p. 278-285
|
article
|
| 12 |
Editorial board
|
|
|
|
20 |
2 |
p. ii-iii
|
article
|
| 13 |
Estrogens, oral contraceptives and hormonal replacement therapy increase the incidence of cutaneous melanoma: a population-based case–control study
|
Koomen, E.R.
|
|
|
20 |
2 |
p. 358-364
|
article
|
| 14 |
Experimental results and related clinical implications of PET detection of epidermal growth factor receptor (EGFr) in cancer
|
Pantaleo, M.A.
|
|
|
20 |
2 |
p. 213-226
|
article
|
| 15 |
High-dose methotrexate combined with procarbazine and CCNU for primary CNS lymphoma in the elderly: results of a prospective pilot and phase II study
|
Illerhaus, G.
|
|
|
20 |
2 |
p. 319-325
|
article
|
| 16 |
High incidence of false-positive PET scans in patients with aggressive non-Hodgkin’s lymphoma treated with rituximab-containing regimens
|
Han, H.S.
|
|
|
20 |
2 |
p. 309-318
|
article
|
| 17 |
Histological type of esophageal cancer might affect response to neo-adjuvant radiochemotherapy and subsequent prognosis
|
Bollschweiler, E.
|
|
|
20 |
2 |
p. 231-238
|
article
|
| 18 |
Hypertension and clinical benefit of bevacizumab in the treatment of advanced renal cell carcinoma
|
Bono, P.
|
|
|
20 |
2 |
p. 393-394
|
article
|
| 19 |
Initial experience with conservative treatment in cancer patients with osteonecrosis of the jaw (ONJ) and predictors of outcome
|
Van den Wyngaert, T.
|
|
|
20 |
2 |
p. 331-336
|
article
|
| 20 |
in this issue
|
|
|
|
20 |
2 |
p. 195
|
article
|
| 21 |
Long-term outcome prediction by clinicopathological risk classification algorithms in node-negative breast cancer—comparison between Adjuvant!, St Gallen, and a novel risk algorithm used in the prospective randomized Node-Negative-Breast Cancer-3 (NNBC-3) trial
|
Schmidt, M.
|
|
|
20 |
2 |
p. 258-264
|
article
|
| 22 |
Loss of enterocyte mass is accompanied by diminished turnover of enterocytes after myeloablative therapy in haematopoietic stem-cell transplant recipients
|
Derikx, J.P.M.
|
|
|
20 |
2 |
p. 337-342
|
article
|
| 23 |
MET increased gene copy number and primary resistance to gefitinib therapy in non-small-cell lung cancer patients
|
Cappuzzo, F.
|
|
|
20 |
2 |
p. 298-304
|
article
|
| 24 |
Randomized study of weekly irinotecan plus high-dose 5-fluorouracil (FUIRI) versus biweekly irinotecan plus 5-fluorouracil/leucovorin (FOLFIRI) as first-line chemotherapy for patients with metastatic colorectal cancer: a Spanish Cooperative Group for the Treatment of Digestive Tumors Study
|
Aranda, E.
|
|
|
20 |
2 |
p. 251-257
|
article
|
| 25 |
Risk of recurrence during follow-up for optimally treated advanced epithelial ovarian cancer (EOC) with a low-level increase of serum CA-125 levels
|
Prat, A.
|
|
|
20 |
2 |
p. 294-297
|
article
|
| 26 |
Rituximab monotherapy for primary cutaneous B-cell lymphoma: response and follow-up in 16 patients
|
Valencak, J.
|
|
|
20 |
2 |
p. 326-330
|
article
|
| 27 |
Sorafenib is active on lung metastases from synovial sarcoma
|
Basso, U.
|
|
|
20 |
2 |
p. 386-387
|
article
|
| 28 |
Stopping a trial early in oncology: for patients or for industry?
|
Bradbury, P.
|
|
|
20 |
2 |
p. 395-396
|
article
|
| 29 |
Successful treatment of primary duodenal carcinoma with bilateral adrenal metastases with docetaxel–cisplatin–5-fluorouracil regimen
|
Bitik, B.
|
|
|
20 |
2 |
p. 394-395
|
article
|
| 30 |
Table of Contents
|
|
|
|
20 |
2 |
p. iv-v
|
article
|
| 31 |
The emerging epidemic of environmental cancers in developing countries
|
Vineis, P.
|
|
|
20 |
2 |
p. 205-212
|
article
|
| 32 |
The impact of obesity and diabetes mellitus on the risk of hepatocellular carcinoma
|
Polesel, J.
|
|
|
20 |
2 |
p. 353-357
|
article
|
| 33 |
The length of consent documents in oncological trials is doubled in twenty years
|
Berger, O.
|
|
|
20 |
2 |
p. 379-385
|
article
|
| 34 |
The quest for the ‘bony Grail’ of detecting circulating tumour cells in patients with prostate cancer
|
Massard, C.
|
|
|
20 |
2 |
p. 197-199
|
article
|
| 35 |
The role of secondary cytoreduction in the management of the first relapse in epithelial ovarian cancer
|
Oksefjell, H.
|
|
|
20 |
2 |
p. 286-293
|
article
|
| 36 |
Thymidine phosphorylase expression and benefit from capecitabine in patients with advanced breast cancer
|
Andreetta, C.
|
|
|
20 |
2 |
p. 265-271
|
article
|
| 37 |
Treatment of hemodialyzed patient with sunitinib
|
Reckova, M.
|
|
|
20 |
2 |
p. 392-393
|
article
|
| 38 |
Trends in quality of end-of-life care for Taiwanese cancer patients who died in 2000–2006
|
Tang, S.T.
|
|
|
20 |
2 |
p. 343-348
|
article
|
| 39 |
Two different first-line 5-fluorouracil regimens with or without oxaliplatin in patients with metastatic colorectal cancer
|
Cunningham, D.
|
|
|
20 |
2 |
p. 244-250
|
article
|
| 40 |
Vitamin D intake and breast cancer risk: a case–control study in Italy
|
Rossi, M.
|
|
|
20 |
2 |
p. 374-378
|
article
|
Journal description